SCHEMBL7284935

SCHEMBL7284935

CN(CCC[O])Cc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.65
CARM1 Q86X55 1/20 0.60
PRMT6 Q96LA8 1/20 0.60
PRMT8 Q9NR22 1/20 0.60
MAOB P27338 5/20 0.57
ACHE P22303 5/20 0.54
MAOA P21397 1/20 0.53
LMNA P02545 1/20 0.53
KDM4A O75164 1/20 0.51
KDM4C Q9H3R0 1/20 0.51
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5828325 0.88 CARM1 (0.64) SIGMAR1CARM1PRMT6PRMT8MAOB
SCHEMBL1088446 0.87 SIGMAR1 (0.74) SIGMAR1CARM1PRMT6PRMT8MAOB
SCHEMBL7225346 0.85 SIGMAR1 (0.85) SIGMAR1CARM1PRMT6PRMT8MAOB
Hydrochloric Acid SCHEMBL1087168 0.85 SIGMAR1 (0.71) SIGMAR1CARM1PRMT6PRMT8MAOB
SCHEMBL29733117 0.85 SIGMAR1 (0.85) SIGMAR1CARM1PRMT6PRMT8MAOB
SCHEMBL7055109 0.83 CARM1 (0.75) SIGMAR1CARM1PRMT6PRMT8MAOB
SCHEMBL20460230 0.82 SIGMAR1 (0.68) SIGMAR1CARM1PRMT6PRMT8MAOB
SCHEMBL2949711 0.82 SIGMAR1 (0.85) SIGMAR1CARM1PRMT6PRMT8
SCHEMBL12359495 0.82 SIGMAR1 (0.67) SIGMAR1CARM1PRMT6PRMT8MAOB
SCHEMBL1638713 0.82 SIGMAR1 (0.67) SIGMAR1CARM1PRMT6PRMT8MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US claimed
EP-0370236-B1 INDOLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-12-27 EP claimed
EP-0362695-B1 PYRROLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-04-03 EP claimed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP claimed
EP-0370236-A1 Indolocarbazole derivatives, processes for their preparation and their use as medicaments GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-05-30 EP claimed
EP-0362695-A1 Pyrrolocarbazole derivatives, processes for their preparation and their use as medicaments GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-04-11 EP claimed
US-4912107-A Pyrrolocarbazole derivatives, compositions containing them, and methods for using them GOEDECKE AKTIENGESELLSCHAFT (DE) 1990-03-27 US claimed
EP-0750607-A1 2-(AMINOALKOXY)PHENYLALKYLAMINES WITH ANTIINFLAMMATORY ACTIVITY Knoll AG (DE) 1997-01-02 EP disclosed
US-5516915-A Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed
US-5508403-A ENHANCES EFFECTS OF ANTITUMOR AGENTS NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1996-04-16 US disclosed
EP-0353692-B1 Drug effect-enhancing agent for antitumor drug NISSAN CHEMICAL IND LTD (JP) 1995-10-04 EP disclosed
WO-1995023127-A1 2-(AMINOALKOXY)PHENYLALKYLAMINES WITH ANTIINFLAMMATORY ACTIVITY KNOLL AG (DE) 1995-08-31 WO disclosed
US-5438050-A Indolocarbazole derivatives, processes for their preparation and compositions containing them GODECKE AKTIENGESELLSCHAFT (DE) 1995-08-01 US disclosed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US disclosed
US-5304550-A Synergistic NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1994-04-19 US disclosed
US-5130303-A Pyridine derivative administering NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-07-14 US disclosed
EP-0370236-B1 INDOLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-12-27 EP disclosed
EP-0362695-B1 PYRROLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-04-03 EP disclosed
US-4912107-A Pyrrolocarbazole derivatives, compositions containing them, and methods for using them GOEDECKE AKTIENGESELLSCHAFT (DE) 1990-03-27 US disclosed
EP-0353692-A2 Drug effect-enhancing agent for antitumor drug NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1990-02-07 EP disclosed